Susan E. Senogles - Publications

Affiliations: 
University of Tennessee Health Science Center, Memphis, TN, United States 
Area:
Biochemistry, Neuroscience Biology

31 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Pi M, Kapoor K, Wu Y, Ye R, Senogles SE, Nishimoto SK, Hwang DJ, Miller DD, Narayanan R, Smith JC, Baudry J, Quarles LD. Structural and Functional Evidence for Testosterone Activation of GPRC6A in Peripheral Tissues. Molecular Endocrinology (Baltimore, Md.). me20151161. PMID 26440882 DOI: 10.1210/Me.2015-1161  0.345
2011 Kendall RT, Senogles SE. Isoform-specific uncoupling of the D2 dopamine receptors subtypes. Neuropharmacology. 60: 336-42. PMID 20888845 DOI: 10.1016/J.Neuropharm.2010.09.018  0.679
2010 Everett PB, Senogles SE. D3 dopamine receptor signals to activation of phospholipase D through a complex with Rho. Journal of Neurochemistry. 112: 963-71. PMID 20021566 DOI: 10.1111/J.1471-4159.2009.06508.X  0.672
2007 Senogles SE. D2 dopamine receptor-mediated antiproliferation in a small cell lung cancer cell line, NCI-H69. Anti-Cancer Drugs. 18: 801-7. PMID 17581302 DOI: 10.1097/Cad.0B013E3280B10D36  0.69
2006 Kendall RT, Senogles SE. Investigation of the alternatively spliced insert region of the D2L dopamine receptor by epitope substitution. Neuroscience Letters. 393: 155-9. PMID 16226376 DOI: 10.1016/J.Neulet.2005.09.057  0.611
2004 Everett PB, Senogles SE. D3 dopamine receptor activates phospholipase D through a pertussis toxin-insensitive pathway. Neuroscience Letters. 371: 34-9. PMID 15500962 DOI: 10.1016/J.Neulet.2004.08.033  0.671
2004 Senogles SE, Heimert TL, Odife ER, Quasney MW. A region of the third intracellular loop of the short form of the D2 dopamine receptor dictates Gi coupling specificity. The Journal of Biological Chemistry. 279: 1601-6. PMID 14581469 DOI: 10.1074/Jbc.M309792200  0.573
2003 Senogles SE. D2s dopamine receptor mediates phospholipase D and antiproliferation. Molecular and Cellular Endocrinology. 209: 61-9. PMID 14604817 DOI: 10.1016/J.Mce.2003.07.001  0.719
2000 Senogles SE. The D2s dopamine receptor stimulates phospholipase D activity: A novel signaling pathway for dopamine Molecular Pharmacology. 58: 455-462. PMID 10908315 DOI: 10.1124/Mol.58.2.455  0.708
2000 Dahmer MK, Senogles SE. Atypical SCH23390 binding sites are present on bovine adrenal medullary membranes Neurochemical Research. 25: 321-326. PMID 10761974 DOI: 10.1023/A:1007569518010  0.686
1998 Quasney MW, Senogles SE. Random mutagenesis of the third intracellular loop of the D2s dopamine receptor Faseb Journal. 12.  0.536
1996 Dahmer MK, Senogles SE. Differential inhibition of secretagogue-stimulated sodium uptake in adrenal chromaffin cells by activation of D4 and D5 dopamine receptors Journal of Neurochemistry. 67: 1960-1964. PMID 8863501 DOI: 10.1046/J.1471-4159.1996.67051960.X  0.649
1996 Dahmer MK, Senogles SE. Dopaminergic inhibition of catecholamine secretion from chromaffin cells: Evidence that inhibition is mediated by D4 and D5 dopamine receptors Journal of Neurochemistry. 66: 222-232. PMID 8522958 DOI: 10.1046/J.1471-4159.1996.66010222.X  0.713
1994 Senogles SE. The D2 dopamine receptor isoforms signal through distinct Giα proteins to inhibit adenylyl cyclase: A study with site-directed mutant Giα proteins Journal of Biological Chemistry. 269: 23120-23127. PMID 7916015  0.677
1994 Senogles SE. The D2 dopamine receptor mediates inhibition of growth in GH4ZR7 cells: Involvement of protein kinase-Cε Endocrinology. 134: 783-789. PMID 7507837 DOI: 10.1210/Endo.134.2.7507837  0.598
1991 Bates MD, Senogles SE, Bunzow JR, Liggett SB, Civelli O, Caron MG. Regulation of responsiveness at D2 dopamine receptors by receptor desensitization and adenylyl cyclase sensitization. Molecular Pharmacology. 39: 55-63. PMID 1846220  0.678
1990 Andersen PH, Gingrich JA, Bates MD, Dearry A, Falardeau P, Senogles SE, Caron MG. Dopamine receptor subtypes: beyond the D1/D2 classification. Trends in Pharmacological Sciences. 11: 231-6. PMID 2200181 DOI: 10.1016/0165-6147(90)90249-8  0.731
1990 Bates MD, Gingrich JA, Bunzow JR, Falardeau P, Dearry A, Senogles SE, Civelli O, Caron MG. Molecular characterization of dopamine receptors. American Journal of Hypertension. 3: 29S-33S. PMID 2143386 DOI: 10.1093/Ajh/3.6.29S  0.655
1990 Senogles SE, Spiegel AM, Padrell E, Iyengar R, Caron MG. Specificity of receptor-G protein interactions. Discrimination of Gi subtypes by the D2 dopamine receptor in a reconstituted system. The Journal of Biological Chemistry. 265: 4507-14. PMID 2137824  0.617
1989 Raymond JR, Fargin A, Lohse MJ, Regan JW, Senogles SE, Lefkowitz RJ, Caron MG. Identification of the ligand-binding subunit of the human 5-hydroxytryptamine1A receptor with N-(p-azido-m-[125I] iodophenethyl)spiperone, a high affinity radioiodinated photoaffinity probe. Molecular Pharmacology. 36: 15-21. PMID 2526292  0.401
1988 Gingrich JA, Amlaiky N, Senogles SE, Chang WK, McQuade RD, Berger JG, Caron MG. Affinity chromatography of the D1 dopamine receptor from rat corpus striatum. Biochemistry. 27: 3907-12. PMID 3415962 DOI: 10.1021/Bi00411A003  0.73
1988 Senogles SE, Amlaiky N, Falardeau P, Caron MG. Purification and characterization of the D2-dopamine receptor from bovine anterior pituitary Journal of Biological Chemistry. 263: 18996-19002. PMID 3143721  0.703
1988 Senogles SE, Amlaiky N, Berger JG, Caron MG. Biochemical properties of D1 and D2 dopamine receptors. Advances in Experimental Medicine and Biology. 235: 33-41. PMID 2976252  0.69
1987 Senogles SE, Benovic JL, Amlaiky N, Unson C, Milligan G, Vinitsky R, Spiegel AM, Caron MG. The D2-dopamine receptor of anterior pituitary is functionally associated with a pertussis toxin-sensitive guanine nucleotide binding protein. The Journal of Biological Chemistry. 262: 4860-7. PMID 3104325  0.591
1986 Senogles SE, Amlaiky N, Johnson AL, Caron MG. Affinity chromatography of the anterior pituitary D2-dopamine receptor Biochemistry. 25: 749-753. PMID 2938619  0.689
1984 Senogles SE, Nelsestuen GL. Reconstitution of functional von Willebrand factor receptor in phospholipid vesicles Federation Proceedings. 43.  0.346
1983 Tollefson GD, Senogles SE. A comparison of first and second generation antidepressants at the human muscarinic cholinergic receptor Journal of Clinical Psychopharmacology. 3: 231-234. PMID 6886034 DOI: 10.1097/00004714-198308000-00005  0.474
1982 Tollefson GD, Senogles SE, Frey WH. Ionic regulation of antagonist binding to the human muscarinic cholinergic receptor of caudate nucleus. Journal of Psychiatric Research. 17: 275-83. PMID 7187689 DOI: 10.1016/0022-3956(82)90006-1  0.497
1981 Nicol SE, Senogles SE, Caruso TP, Hudziak JJ, McSwigan JD, Frey WH. Postmortem stability of dopamine-sensitive adenylate cyclase, guanylate cyclase, ATPase, and GTPase in rat striatum. Journal of Neurochemistry. 37: 1535-9. PMID 6120996 DOI: 10.1111/J.1471-4159.1981.Tb06324.X  0.423
1981 Frey WH, Senogles SE, Tuason VB, Nicol SE. Stimulation of guanylate cyclase by EDTA and other chelating agents. Biochimica Et Biophysica Acta. 658: 369-76. PMID 6113847 DOI: 10.1016/0005-2744(81)90307-7  0.376
1980 Frey WH, Senogles SE, Heston LL, Tuason VB, Nicol SE. Catecholamine-sensitive guanylate cyclase from human caudate nucleus. Journal of Neurochemistry. 35: 1418-30. PMID 6108353 DOI: 10.1111/J.1471-4159.1980.Tb09018.X  0.413
Show low-probability matches.